YONKE’AM ILLIT, Israel—Lumenis has announced its partnership with singer-songwriter and actress Mandy Moore as brand ambassador for OptiLight, a solution for dry eyes. Moore suffered from dry eye disease and treatment with OptiLight improved her condition, and she is now partnering with Lumenis to share her story. She will star in OptiLight’s new campaign, which aims to show dry eye sufferers that they do not have to “just live with it,” the company said in an announcement.

The “Not Gonna Live With It Generation” campaign featuring Moore debuted this week with a commercial as well as a digital and print media campaign to encourage people to learn more about dry eye disease and find effective therapy with OptiLight. The commercial is available to watch online here.

Moore said, “I’m excited to partner with Lumenis and share how OptiLight has made a real impact on my life. For years, I suffered from dry eye disease, but I didn’t know I had it. My eyes felt gritty and tired, and they looked red. I couldn’t wear my contact lenses for long. Eye drops didn’t do much. It was a constant frustration on the set and at home with my family.

"When I learned that I had a medical condition called dry eye disease, I realized I didn’t have to just live with it—I could get a safe, effective treatment with OptiLight. Now, I can focus more time on what’s important to me, rather than battling the constant nuisance and discomfort of dry eye disease, and I want to inspire other people to say, ‘I won’t just live with it.’”

Lumenis CEO Tzipi Ozer-Armon said, “Lumenis is thrilled to partner with Mandy Moore for this important campaign, which will raise awareness of dry eye disease and introduce the groundbreaking treatment with OptiLight. OptiLight with patented Optimal Pulse Technology (OPT) is the only light therapy for the management of dry eye disease.

"For millions of people who share Mandy’s experience with this condition, OptiLight is a perfect fit. Our ability to improve the quality of life for those who suffer from dry eye disease is why we do what we do, so it’s wonderful to see her enthusiasm for OptiLight and the results of her treatment. We hope it will inspire others to get better care for dry eye disease,” Ozer-Armon said.

OptiLight is the first and only light-based therapy for dry eye disease. As part of a treatment regimen, it helps improve dry eye disease with a series of quick, gentle in-office treatments.